Stephen Toth
Hospitalist · Omaha, NENPI 1013588342
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 47.5% of the total. 2025 is the largest year on record at $1,485, more than ten times the $124 reported in 2022. Among hospitalist clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $28.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$959
- Merck$142
- BD$109
- Jazz Pharmaceuticals Inc.$96
- Insmed, Inc.$89
- United Therapeutics Corporation$86
- plus $540 from 16 others
What the payments were for
- Food & beverage$1,98598%
- Education$362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $959 |
| Merck | 5 | $142 |
| BD | 1 | $109 |
| Jazz Pharmaceuticals Inc. | 5 | $96 |
| Insmed, Inc. | 4 | $89 |
| United Therapeutics Corporation | 1 | $86 |
| Amgen | 4 | $66 |
| Boehringer Ingelheim | 3 | $55 |
| Viatris Specialty LLC | 3 | $49 |
| Sanofi | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 3 | $45 |
| Baxter Healthcare | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Verona Pharma, Inc. | 2 | $34 |
| Abiomed | 1 | $31 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Ambu Inc. | 1 | $20 |
| AbbVie | 1 | $17 |
| GSK | 1 | $16 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$489
- AIRSUPRA$248
- BREZTRI$128
- TEZSPIRE$128
- HemoSphere$109
How this compares
$2,021 in reported general payments places this provider in the 95th percentile of 124 hospitalist providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Omaha
- Bryce SchutteOmaha$2K
- Anthony MacdissiOmaha$2K
- Joseph ThirumalareddyOmaha$2K
- Sunil NairOmaha$1K
- Adam MacdissiOmaha$1K
- Akshat SoodOmaha$1K
- Pooja DeshmukhOmaha$1K
- Jill PuetzOmaha$975
- Durgalakshmi DuraikannanOmaha$907
- Rebecca StrattonOmaha$877
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.